Sandoz Group AG (SDZNY)
35.15
+0.06
(+0.17%)
USD |
OTCM |
May 22, 16:15
Sandoz Group Revenue (TTM): 645.62M for March 31, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 645.62M |
| December 31, 2023 | 821.38M |
| September 30, 2023 | 1.453B |
| June 30, 2023 | 1.273B |
| March 31, 2023 | 1.137B |
| Date | Value |
|---|---|
| December 31, 2022 | 1.145B |
| September 30, 2022 | 1.099B |
| June 30, 2022 | 1.055B |
| March 31, 2022 | 1.003B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
645.62M
Minimum
Mar 2024
1.453B
Maximum
Sep 2023
1.070B
Average
1.099B
Median
Sep 2022
Revenue (TTM) Benchmarks
| Novartis AG | 49.92B |
| AC Immune SA | -- |
| CRISPR Therapeutics AG | -- |
| Addex Therapeutics Ltd | 1.787M |
| NLS Pharmaceutics Ltd | -- |